Developer docs
API playgroundTry for free, no card

Search company profiles

Aspire IRB

Full company profile

uuid000bsz4

Namestring
Aspire IRB
Legal namestring
WCG Clinical
Websiteurl
aspire-irb.com
Company typeenum
Private
Founded yearint
1969
Descriptiontext

Aspire IRB is an independent institutional review board (IRB) founded in 2004 and headquartered in Santee, California. It provides ethical and regulatory review services for clinical research studies conducted across pharmaceutical, biotechnology, medical device, academic, and social/behavioral research settings. The firmographic profile indicates a small biotech-stage entity with 11-50 employees.

The detailed operational evidence available for the broader WCG Clinical IRB infrastructure (with which Aspire IRB is associated) shows a review capability built around a panel of nearly 200 IRB professionals, supported by Board Certified IRB Professionals (CIPs) and accredited under AAHRPP and ISO 9001 standards. Service offerings span central IRB review, IRB reliance and cede/review arrangements, specialized therapeutic-area boards (Oncology, CNS, Cardiovascular, Medical Device, Social/Behavioral), and ancillary compliance services such as biosafety, conflict-of-interest review, and IBC administration. The technology stack includes proprietary platforms ClinSphere (with a Trial IntelX insights module), IRBNet, and an ePay system for fee processing, alongside a Central Sites Network that connects reviewed protocols to clinical trial sites. Operations run 7 days a week, 365 days a year.

The business model is fee-for-service, with quote-based, customized pricing per study and engagement-based multi-year contracting for enterprise sponsors. Go-to-market is anchored on direct relationships with large pharma (Genentech), global CROs (PPD), academic medical centers, and federal/non-federal grant-funded researchers. Revenue mechanics derive from per-study review fees, ancillary service charges, and platform access for sponsor and site workflow management. Geographic reach includes U.S. coverage and a Canadian IRB board serving cross-border trials, with a Phase I capability added via a partnership with Dr. Vince Clinical Research.

Short descriptiontext

Aspire IRB is an independent institutional review board founded in 2004 in Santee, California, providing ethical and regulatory review services for clinical research studies across pharmaceutical, biotech, medical device, academic, and behavioral research sponsors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSantee, United States
HQ citystring
Santee
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
IRB review services, ethical review board, clinical research compliance, institutional biosafety review, clinical trial approvals
Industry2 codes
PRIMARYHLAJACAG
Clinical Research Ethics & Human Subjects Protection Authorities (IRB/REC Oversight)
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Policy, Regulation & Compliance Authorities
SECONDARYEDADAKAH
Research Administration & Compliance (Sponsored Programs, IRB/REB)
Education/Education Administration, Accreditation & Policy/Institutional Governance & Administration (School/College/University Admin)
NAICS code1 code
  • Other Scientific and Technical Consulting Services541690
SIC code1 code
  • Services-Computer Programming Services7371
Product category
Clinical Research Ethics Review (IRB Services)
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1IRB Review Services
TypeSubscription Recurring
Description

Fee-based ethical review services for clinical research studies including pharmaceutical trials, medical device studies, biologics research, and pediatric studies. Revenue generated through per-study review fees with various service tiers including standard and accelerated (IRB+) options.

wcgclinical.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details2 tiers
1Standard IRB Review
ModelOtherBilling cadenceMulti-year contract
Notes

Fee-based per-study review; specific pricing available upon request via fee schedule request form

wcgclinical.com
2IRB+ Accelerated Service
ModelOtherBilling cadenceMulti-year contract
Notes

Premium expedited service for studies requiring accelerated processing and white-glove handling

wcgclinical.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 2 records shown
1ClinSphere eReview Manager
Description

Modern user interface for IRB review workflows with real-time collaboration and efficiency features.

wcgclinical.com
+1 more record
Core offering1 text field

Aspire IRB provides independent ethical review (IRB) services for clinical research studies, covering pharmaceutical trials, medical device studies, biologics research, pediatric research, and social/behavioral studies. Services include standard IRB review plus an accelerated IRB+ tier with white-glove expedited processing. The company also delivers Institutional Biosafety Committee (IBC) review services for studies involving gene transfer and biologics, supported by submission portals such as ClinSphere and eReview Manager.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Less than 6 days for new protocol determinations from submission to document delivery
+2 more records
Product overview1 text field

WCG (formerly WCG Clinical) operates as a unified platform-plus-services provider for the clinical research industry, centered on its ClinSphere™ platform which integrates multiple sub-products including eReview Manager, AIMS®, IRBNet, InvestigatorSpace®, and Trial IntelX™. The company's core offering is IRB Review services augmented by specialized review services for pharmaceuticals, medical devices, biologics, pediatrics, and social/behavioral research. Additional technology solutions include Total Enrollment, Total Feasibility, eResearch Enterprise CTMS, and Clinical Trial Listing Service. The portfolio also encompasses study enablement services such as participant recruitment, clinical trial training, site network access, and data monitoring committees, all designed to accelerate clinical trial timelines from study planning through completion.

Product and service5 records
1IRB Review
CategoryIRB review services
Description

Independent ethical review service for clinical research protocols, utilizing a custom board of nearly 200 WCG IRB experts augmented by an extensive clinical advisory network to provide swift protocol determinations for sponsors and investigators.

2IRB+ Accelerated Service
CategoryIRB review services
Description

Accelerated IRB review service with white-glove support for studies requiring expedited processing, enabling faster study start-up without compromising quality and integrity of ethical review.

3IBC Review
CategoryBiosafety committee services
Description

Institutional Biosafety Committee review services for clinical studies involving biologics, gene transfer protocols, CAR-T, T-cells, B-cells, stem cells, viral vectors, and other biological materials manufactured from living cells and tissue.

4Canadian Board Review
CategoryIRB review services
Description

Comprehensive ethical review services for clinical studies conducted within Canadian Provinces, compliant with Health Canada Division 5 regulations, with board members who are Canadian citizens or permanent residents.

5Pediatric IRB Review
CategoryIRB review services
Description

Specialized IRB review for clinical research involving children as subjects, including parental permission documentation, child assent forms, and four categories of pediatric research approval with additional regulatory and ethical protections.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-09-13
Description

Strategic partnership to expand Phase I review services. Dr. Vince Clinical Research brings Phase I investigator expertise to enhance WCG's review capabilities for first-in-human studies and residential clinical trials requiring extended monitoring.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Formed from the merger of Chesapeake IRB and Schulman IRB (later absorbing Quorum Review IRB), Advarra is the other dominant independent central IRB serving pharma, device, and academic sponsors with overlapping IRB, IBC, and research compliance services.

TypeBroad incumbent
Description

A top global CRO whose post-2021 PRA Health Sciences acquisition created a broad clinical services portfolio overlapping with WCG's IRB-adjacent technology, feasibility, and trial enablement offerings.

TypeDirect peer
Description

An AAHRPP-accredited independent central IRB offering ethical review for clinical trials across multiple therapeutic areas, competing head-to-head with WCG for sponsor review contracts.

TypeBroad incumbent
Description

The world's largest CRO, offering a broad portfolio of clinical trial services that includes IRB coordination and ethics oversight as part of its integrated biopharma services — competing with WCG's ClinSphere platform ambitions.

TypeBroad incumbent
Description

A major central laboratory and clinical development services provider whose clinical trial offerings overlap with WCG's study-enablement and central review-adjacent services for sponsors and CROs.

TypeEmerging player
Description

A clinical trial technology vendor (formed from ERT and Bioclinica) offering eCOA, imaging, and trial-management platforms that compete with WCG's ClinSphere platform and adjacent study-enablement technology stack.

TypeDirect peer
Description

A long-standing independent central IRB (Quorum) that spun out its ethical-review business into Kinetiq, offering IRB and IBC services for clinical research sponsors across North America.

TypeDirect peer
Description

An independent central IRB providing protocol review services for pharmaceutical, device, and behavioral research — a direct competitor in the same central IRB category as WCG.

TypeBroad incumbent
Description

A large preclinical and clinical services provider whose Discovery & Safety Assessment and clinical manufacturing offerings intersect with WCG's biologics/IBC review work and broader clinical research support.

TypeEmerging player
Description

A consortium-based IRB serving academic medical centers and industry sponsors with central IRB services, particularly in the Northeast US, directly overlapping WCG's academic and hospital-facing review work.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Aspire IRB

Clinical Research Ethics Review (IRB Services)aspire-irb.com

Aspire IRB is an independent institutional review board founded in 2004 in Santee, California, providing ethical and regulatory review services for clinical research studies across pharmaceutical, biotech, medical device, academic, and behavioral research sponsors.

What Aspire IRB does

Aspire IRB is an independent institutional review board (IRB) founded in 2004 and headquartered in Santee, California. It provides ethical and regulatory review services for clinical research studies conducted across pharmaceutical, biotechnology, medical device, academic, and social/behavioral research settings. The firmographic profile indicates a small biotech-stage entity with 11-50 employees.

The detailed operational evidence available for the broader WCG Clinical IRB infrastructure (with which Aspire IRB is associated) shows a review capability built around a panel of nearly 200 IRB professionals, supported by Board Certified IRB Professionals (CIPs) and accredited under AAHRPP and ISO 9001 standards. Service offerings span central IRB review, IRB reliance and cede/review arrangements, specialized therapeutic-area boards (Oncology, CNS, Cardiovascular, Medical Device, Social/Behavioral), and ancillary compliance services such as biosafety, conflict-of-interest review, and IBC administration. The technology stack includes proprietary platforms ClinSphere (with a Trial IntelX insights module), IRBNet, and an ePay system for fee processing, alongside a Central Sites Network that connects reviewed protocols to clinical trial sites. Operations run 7 days a week, 365 days a year.

The business model is fee-for-service, with quote-based, customized pricing per study and engagement-based multi-year contracting for enterprise sponsors. Go-to-market is anchored on direct relationships with large pharma (Genentech), global CROs (PPD), academic medical centers, and federal/non-federal grant-funded researchers. Revenue mechanics derive from per-study review fees, ancillary service charges, and platform access for sponsor and site workflow management. Geographic reach includes U.S. coverage and a Canadian IRB board serving cross-border trials, with a Phase I capability added via a partnership with Dr. Vince Clinical Research.

Aspire IRB firmographics

Firmographics
Name
Aspire IRB
Legal name
WCG Clinical
Website
https://aspire-irb.com
Company type
Private
Founded year
1969
Operating status
Operating
Headcount range
11–50 employees
Short description
Aspire IRB is an independent institutional review board founded in 2004 in Santee, California, providing ethical and regulatory review services for clinical research studies across pharmaceutical, biotech, medical device, academic, and behavioral research sponsors.
Ownership category
akta.pro rank

Aspire IRB industry classification

Industry
Product category
Clinical Research Ethics Review (IRB Services)
NAICS
Other Scientific and Technical Consulting Services (541690)
SIC
Services-Computer Programming Services (7371)
akta.pro industry
PRIMARYHLAJACAG
Clinical Research Ethics & Human Subjects Protection Authorities (IRB/REC Oversight)
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Policy, Regulation & Compliance Authorities
SECONDARYEDADAKAH
Research Administration & Compliance (Sponsored Programs, IRB/REB)
Education/Education Administration, Accreditation & Policy/Institutional Governance & Administration (School/College/University Admin)

Keywords

  • IRB review services
  • Ethical review board
  • Clinical research compliance
  • Institutional biosafety review
  • Clinical trial approvals

Where Aspire IRB is headquartered

Location

Headquarters

HQ city
Santee
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Aspire IRB business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. IRB Review Services: Fee-based ethical review services for clinical research studies including pharmaceutical trials, medical device studies, biologics research, and pediatric studies. Revenue generated through per-study review fees with various service tiers including standard and accelerated (IRB+) options.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractStandard IRB Review
OtherMulti-year contractIRB+ Accelerated Service

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Aspire IRB product offering

Product offering

Core offering

Aspire IRB provides independent ethical review (IRB) services for clinical research studies, covering pharmaceutical trials, medical device studies, biologics research, pediatric research, and social/behavioral studies. Services include standard IRB review plus an accelerated IRB+ tier with white-glove expedited processing. The company also delivers Institutional Biosafety Committee (IBC) review services for studies involving gene transfer and biologics, supported by submission portals such as ClinSphere and eReview Manager.

Product overview

WCG (formerly WCG Clinical) operates as a unified platform-plus-services provider for the clinical research industry, centered on its ClinSphere™ platform which integrates multiple sub-products including eReview Manager, AIMS®, IRBNet, InvestigatorSpace®, and Trial IntelX™. The company's core offering is IRB Review services augmented by specialized review services for pharmaceuticals, medical devices, biologics, pediatrics, and social/behavioral research. Additional technology solutions include Total Enrollment, Total Feasibility, eResearch Enterprise CTMS, and Clinical Trial Listing Service. The portfolio also encompasses study enablement services such as participant recruitment, clinical trial training, site network access, and data monitoring committees, all designed to accelerate clinical trial timelines from study planning through completion.

Differentiator

Problem solved

Functional benefit

Brands

  • ClinSphere eReview Manager: Modern user interface for IRB review workflows with real-time collaboration and efficiency features.
  • IRB+

Products and services

  • IRB Review Independent ethical review service for clinical research protocols, utilizing a custom board of nearly 200 WCG IRB experts augmented by an extensive clinical advisory network to provide swift protocol determinations for sponsors and investigators.
  • IRB+ Accelerated Service Accelerated IRB review service with white-glove support for studies requiring expedited processing, enabling faster study start-up without compromising quality and integrity of ethical review.
  • IBC Review Institutional Biosafety Committee review services for clinical studies involving biologics, gene transfer protocols, CAR-T, T-cells, B-cells, stem cells, viral vectors, and other biological materials manufactured from living cells and tissue.
  • Canadian Board Review Comprehensive ethical review services for clinical studies conducted within Canadian Provinces, compliant with Health Canada Division 5 regulations, with board members who are Canadian citizens or permanent residents.
  • Pediatric IRB Review Specialized IRB review for clinical research involving children as subjects, including parental permission documentation, child assent forms, and four categories of pediatric research approval with additional regulatory and ethical protections.

Quantifiable outcome

  • Less than 6 days for new protocol determinations from submission to document delivery
  • +2 more outcomes

Companies that use Aspire IRB

Customer profile

Named customers3 records

Segments7 records

Ideal customer profiles4 records

Aspire IRB technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Aspire IRB partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Dr. Vince Clinical ResearchcoreStrategic or Co-development Partner · 13 September 2022Strategic partnership to expand Phase I review services. Dr. Vince Clinical Research brings Phase I investigator expertise to enhance WCG's review capabilities for first-in-human studies and residential clinical trials requiring extended monitoring.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Aspire IRB competitors and assessment

Company assessment

Direct peers

  • Advarra: Formed from the merger of Chesapeake IRB and Schulman IRB (later absorbing Quorum Review IRB), Advarra is the other dominant independent central IRB serving pharma, device, and academic sponsors with overlapping IRB, IBC, and research compliance services.
  • IntegReview IRB: An AAHRPP-accredited independent central IRB offering ethical review for clinical trials across multiple therapeutic areas, competing head-to-head with WCG for sponsor review contracts.
  • Quorum Review IRB / Kinetiq: A long-standing independent central IRB (Quorum) that spun out its ethical-review business into Kinetiq, offering IRB and IBC services for clinical research sponsors across North America.
  • Sterling IRB: An independent central IRB providing protocol review services for pharmaceutical, device, and behavioral research — a direct competitor in the same central IRB category as WCG.

Broad incumbents

  • ICON plc: A top global CRO whose post-2021 PRA Health Sciences acquisition created a broad clinical services portfolio overlapping with WCG's IRB-adjacent technology, feasibility, and trial enablement offerings.
  • IQVIA: The world's largest CRO, offering a broad portfolio of clinical trial services that includes IRB coordination and ethics oversight as part of its integrated biopharma services — competing with WCG's ClinSphere platform ambitions.
  • Labcorp Drug Development (formerly Covance): A major central laboratory and clinical development services provider whose clinical trial offerings overlap with WCG's study-enablement and central review-adjacent services for sponsors and CROs.
  • Charles River Laboratories: A large preclinical and clinical services provider whose Discovery & Safety Assessment and clinical manufacturing offerings intersect with WCG's biologics/IBC review work and broader clinical research support.

Emerging players

  • Clario: A clinical trial technology vendor (formed from ERT and Bioclinica) offering eCOA, imaging, and trial-management platforms that compete with WCG's ClinSphere platform and adjacent study-enablement technology stack.
  • BRANY (Biomedical Research Alliance of New York): A consortium-based IRB serving academic medical centers and industry sponsors with central IRB services, particularly in the Northeast US, directly overlapping WCG's academic and hospital-facing review work.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Aspire IRB social profiles

Digital presence

Aspire IRB compliance and trust

Trust signal

Compliance2 records

Aspire IRB financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Aspire IRB leadership team

Management profile

Number of profiles

Profiles1 record

Aspire IRB funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Aspire IRB M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aspire IRB

What does Aspire IRB do?

Aspire IRB provides independent ethical review (IRB) services for clinical research studies, covering pharmaceutical trials, medical device studies, biologics research, pediatric research, and social/behavioral studies. Services include standard IRB review plus an accelerated IRB+ tier with white-glove expedited processing. The company also delivers Institutional Biosafety Committee (IBC) review services for studies involving gene transfer and biologics, supported by submission portals such as ClinSphere and eReview Manager.

Is Aspire IRB a public or private company?

Aspire IRB is a private company. It is classified as unknown and is currently operating.

When was Aspire IRB founded?

Aspire IRB was founded in 1969. It employs 11 to 50 people.

Where is Aspire IRB based?

Aspire IRB is headquartered in Santee, United States, in the North America region.

How does Aspire IRB make money?

One revenue line is on record: IRB Review Services.

Who are Aspire IRB's main competitors?

Direct peers on record are Advarra, IntegReview IRB, Quorum Review IRB / Kinetiq and Sterling IRB. Broad incumbents are ICON plc, IQVIA, Labcorp Drug Development (formerly Covance) and Charles River Laboratories. Emerging players are Clario and BRANY (Biomedical Research Alliance of New York).

Does Aspire IRB have an API?

No public API is recorded for Aspire IRB.

What industry is Aspire IRB in?

Aspire IRB's product category is Clinical Research Ethics Review (IRB Services). Its primary akta.pro industry code is HLAJACAG, Clinical Research Ethics & Human Subjects Protection Authorities (IRB/REC Oversight), with a secondary code of EDADAKAH, Research Administration & Compliance (Sponsored Programs, IRB/REB). Its NAICS code is 541690 and its SIC code is 7371.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales